Carolina Pola
Chief Executive Officer Stab Therapeutics
Multidisciplinary scientific professional with 12 years of experience in building relationships and communicating with different stakeholders in biomedicine including KOLs, foundations, science policy makers and business around the world. Expertise in identifying translational science in the biomedical space and developing scientific and business strategy with a broad understanding of launching new ventures and developing strategic roadmaps to bring discoveries closer to the market. Eager to continue developing my professional career within the field of innovation to provide support to research & innovation strategy and management, scientific scouting, business development and scientific relations expertise for innovative projects.
Seminars
- Explore how STAb-T cells combine the precision of cell therapy with the versatility of bispecific antibodies to achieve durable tumour control
- Highlight emerging preclinical data demonstrating their potential to enhance targeting breadth and induce sustained responses
- Discuss how investment headwinds are shaping company strategies and what it takes to sustain progress in Europe
- Highlight the most promising scientific advances, including novel indications, armouring strategies, and in-vivo approaches
- Explore how patient access models, from point-of-care manufacturing to evolving reimbursement pathways, can unlock future growth
